Elexacaftor/tezacaftor/ivacaftor improves CFTR function to near-normal levels in children with cystic fibrosis.
- DOI
- 10.1183/13993003.00422-2026
- Published
- 2026 Sep 24
- Container
- The European respiratory journal
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1183/13993003.00422-2026,
title = {Elexacaftor/tezacaftor/ivacaftor improves CFTR function to near-normal levels in children with cystic fibrosis.},
author = {Berger J and Yu Y and Berges J and González A and Rossow V and Hämmerling S and Morty RE and Thee S and Stahl M and Sommerburg O and Mall MA and Graeber SY},
year = {2026},
journal = {The European respiratory journal},
doi = {10.1183/13993003.00422-2026},
url = {https://doi.org/10.1183/13993003.00422-2026}
}RIS
TY - JOUR TI - Elexacaftor/tezacaftor/ivacaftor improves CFTR function to near-normal levels in children with cystic fibrosis. AU - Berger J AU - Yu Y AU - Berges J AU - González A AU - Rossow V AU - Hämmerling S AU - Morty RE AU - Thee S AU - Stahl M AU - Sommerburg O AU - Mall MA AU - Graeber SY PY - 2026 JO - The European respiratory journal DO - 10.1183/13993003.00422-2026 UR - https://doi.org/10.1183/13993003.00422-2026 ER -
APA
J, B., Y, Y., J, B., A, G., V, R., S, H., RE, M., S, T., M, S., O, S., MA, M., & SY, G. (2026). Elexacaftor/tezacaftor/ivacaftor improves CFTR function to near-normal levels in children with cystic fibrosis.. The European respiratory journal. https://doi.org/10.1183/13993003.00422-2026
Source records
- pubmed · retrieved 2026-09-25T07:00:42.478Z